RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NVO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Thursday for Novo Nordisk A/S stock after gaining 0.273%
(Updated on Mar 28, 2024)

Buy or Hold candidate since Dec 20, 2023 Gain 26.74% PDF

The Novo Nordisk A/S stock price gained 0.273% on the last trading day (Thursday, 28th Mar 2024), rising from $128.05 to $128.40. During the last trading day the stock fluctuated 1.85% from a day low at $127.79 to a day high of $130.16. The price has fallen in 6 of the last 10 days and is down by -4.59% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 155 thousand more shares were traded than the day before. In total, 4 million shares were bought and sold for approximately $449.46 million.

Given the current short-term trend, the stock is expected to rise 29.33% during the next 3 months and, with a 90% probability hold a price between $166.06 and $186.17 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NVO Signals & Forecast

The Novo Nordisk A/S stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $129.12. On a fall, the stock will find some support from the long-term average at approximately $126.63. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, March 07, 2024, and so far it has fallen -5.53%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Novo Nordisk A/S stock

On the downside, the stock finds support just below today's level from accumulated volume at $114.74 and $109.02. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Novo Nordisk A/S finds support just below today's level at $114.74. If this is broken, then the next support from accumulated volume will be at $109.02 and $107.63.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.37 between high and low, or 1.85%. For the last week, the stock has had daily average volatility of 1.30%.

Our recommended stop-loss: $122.22 (-4.81%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 15 days ago.)

Trading Expectations (NVO) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Novo Nordisk A/S to open at $128.78, and during the day (based on 14 day Average True Range), to move between $125.53 and $131.27, which gives a possible trading interval of +/-$2.87 (+/-2.23%) up or down from last closing price. If Novo Nordisk A/S takes out the full calculated possible swing range there will be an estimated 4.47% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $133.07 (3.64%) than the support at $114.74 (10.64%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Novo Nordisk A/S stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Novo Nordisk A/S stock to perform well in the short-term.

Current score: 4.374 Buy Candidate Unchanged

Predicted Opening Price for Novo Nordisk A/S of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$128.78 ( 0.299%) $128.40

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NVO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 131.15 2.14 %
R2 130.25 1.44 %
R1 129.69 1.00 %
Current price: 128.40
Support S1 127.88 -0.407 %
S2 127.32 -0.84 %
S3 126.41 -1.55 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 135.92 5.86 %
R2 133.49 3.96 %
R1 133.07 3.64 %
Current price 128.40
Support S1 114.74 -10.64%
S2 109.02 -15.09%
S3 107.63 -16.18%

NVO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jan 31, 2024 Mar 22, 2024 Apr 02, 2024 $0.93 0.724%
2 Aug 10, 2023 Aug 18, 2023 Aug 29, 2023 $0.88 0.93%
3 Feb 02, 2023 Mar 24, 2023 Apr 04, 2023 $1.19 1.50%
4 Aug 05, 2022 Aug 12, 2022 Aug 23, 2022 $0.584 1.10%
5 Mar 02, 2022 Mar 25, 2022 Apr 05, 2022 $1.04 1.80%

FAQ

What is the symbol for Novo Nordisk A/S Stock and on which exchange is it traded?
The symbol for Novo Nordisk A/S is NVO and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Novo Nordisk A/S Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Novo Nordisk A/S stock to perform well in the short-term.

How to buy Novo Nordisk A/S Stock?
Novo Nordisk A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Novo Nordisk A/S Stock.

What's the current price of Novo Nordisk A/S Stock?
As of the end of day on the 2024-03-28, the price of an Novo Nordisk A/S (NVO) share was $128.40.

What is the 52-week high and low for Novo Nordisk A/S Stock?
The 52-week high for Novo Nordisk A/S Stock is $138.27 and the 52-week low is $75.56.

What is the market capitalization of Novo Nordisk A/S Stock?
As of the 2024-03-28, the market capitalization of Novo Nordisk A/S is 573.185B.

When is the next earnings date for Novo Nordisk A/S?
The upcoming earnings date for Novo Nordisk A/S is May 02, 2024.
Click to get the best stock tips daily for free!

About Novo Nordisk A/S

Novo Nordisk A/S Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the ... NVO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT